Immunologic studies of rabies vaccination-induced guillain-barré syndrome

Thiravat Hemachudha, Diane E. Griffin, Winston W. Chen, Richard T. Johnson

Research output: Contribution to journalArticle

Abstract

Patients with Guillain-Barre syndrome (GBS) induced by rabies vaccines prepared from either suckling mouse brain (SMB) or mature sheep brain (Semple vaccine) and patients with sporadic, idiopathic GBS were studied for antibody to myelin basic protein (MBP), P2 protein, and Schwann cells. Sera from all four Semple vaccine- and one of five SMB vaccine-induced GBS patients, but none of the sporadic GBS patients, had antibody to MBP. Sera from Semple vaccinees also had antibody to fixed, transformed Schwann cells, but similar amounts of antibody were found in sera from Semple vaccinees with CNS complications and with minor non-neurologic complications, suggesting that this antibody was not specifically linked to the development of polyneuritis. None of the sera had detectable antibody to P2 protein. We conclude that patients with GBS constitute a heterogeneous population and that different target antigens may serve as a focus for this presumed autoimmune disease.

Original languageEnglish (US)
Pages (from-to)375-378
Number of pages4
JournalNeurology
Volume38
Issue number3
DOIs
StatePublished - Mar 1988

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Immunologic studies of rabies vaccination-induced guillain-barré syndrome'. Together they form a unique fingerprint.

  • Cite this